Receive our newsletter – data, insights and analysis delivered to you
July 13, 2009

Teva’s One-Step Emergency Contraceptive gets FDA Approval

Teva Pharmaceutical has received approval from the US Food and Drug Administration (FDA) for its Plan B One-Step emergency contraceptive. The FDA gave approval following a successful New Drug Application for the tablet (levonorgestrel tablet, 1.5mg), which can be used after unprotected se

By cms admin

Teva Pharmaceutical has received approval from the US Food and Drug Administration (FDA) for its Plan B One-Step emergency contraceptive.

The FDA gave approval following a successful New Drug Application for the tablet (levonorgestrel tablet, 1.5mg), which can be used after unprotected sex or contraceptive failure with just one pill in one dose.

The FDA is now deciding whether to expand over-the-counter access for the contraceptive to consumers aged 17 or older.

Teva Women’s Health general manager and senior vice-president Amy Niemann said that the company was proud to offer women this new and innovative emergency contraceptive option that builds on the trust women have come to know with Plan B.

“Emergency contraception is more effective the sooner it’s taken, and with Plan B One-Step women can act quickly and take it right away when the unexpected happens,” Niemann said.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU